Stories > Europe Approves CRISPR Gene-Edited Therapy for Sickle Cell Disease

Europe Approves CRISPR Gene-Edited Therapy for Sickle Cell Disease

Advancements in Cancer Treatment and Mar...

Biotech Innovations and Financing

Biotech Updates and Market Projections

4DMT Presents Positive Interim Data

Advancements in Gene Editing and Cancer ...

Biotech Collaboration Enhances CRISPR In...